TI
WST icon

tru Independence’s West Pharmaceutical WST Stock Holding History

tru Independence’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$233K Buy
+650
New +$199K 0.1% 95
2025
Q1 		– Sell
-886
Closed -$290K – 118
2024
Q4 		$290K Sell
886
-21
-2% -$6.61K 0.09% 96
2024
Q3 		$272K Hold
907
– – 0.08% 101
2024
Q2 		$299K Sell
907
-47
-5% -$16.6K 0.09% 91
2024
Q1 		$378K Sell
954
-3
-0.3% -$1.11K 0.11% 87
2023
Q4 		$337K Sell
957
-2
-0.2% -$708 0.1% 92
2023
Q3 		$360K Buy
959
+21
+2% +$8.12K 0.12% 93
2023
Q2 		$359K Sell
938
-2
-0.2% -$714 0.12% 89
2023
Q1 		$326K Sell
940
-2
-0.2% -$584 0.11% 93
2022
Q4 		$222K Sell
942
-2
-0.2% -$474 0.07% 108
2022
Q3 		$232K Sell
944
-1
-0.1% -$305 0.08% 107
2022
Q2 		$286K Sell
945
-3
-0.3% -$976 0.09% 108
2022
Q1 		$389K Sell
948
-2
-0.2% -$783 0.11% 111
2021
Q4 		$446K Sell
950
-3
-0.3% -$1.29K 0.12% 104
2021
Q3 		$405K Buy
+953
New +$402K 0.11% 105
2021
Q1 		– Sell
-737
Closed -$209 – 722
2020
Q4 		$209 Buy
+737
New +$207K ﹤0.01% 425
2020
Q3 		– Sell
-21
Closed -$5K – 862
2020
Q2 		$5K Hold
21
– – ﹤0.01% 710
2020
Q1 		$3K Hold
21
– – ﹤0.01% 609
2019
Q4 		$3K Buy
+21
New +$3.06K ﹤0.01% 778

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

tru Independence's WST Position: Q2 2026 in Review

tru Independence opened a new position in West Pharmaceutical (WST) in Q2 2026: 650 shares worth $233K. The stake represents 0.1% of the portfolio and ranks #95 among its holdings. This is a return to the name: tru Independence previously reported a position in WST as recently as Q4 2024.

tru Independence first reported a position in WST in Q4 2019 and has held it in 19 quarters since. The position peaked at $446K in Q4 2021. 830 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • tru Independence held 650 shares of West Pharmaceutical worth $233K as of Q2 2026.
  • West Pharmaceutical was a new tru Independence position in Q2 2026.
  • West Pharmaceutical made up 0.1% of tru Independence's portfolio in Q2 2026, its #95 holding.
  • tru Independence first reported a position in West Pharmaceutical in Q4 2019 and has held it in 19 quarters since.
  • tru Independence's West Pharmaceutical position peaked at $446K in Q4 2021.
  • 830 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on tru Independence's 13F filing for Q2 2026, filed 10 Aug 2026.